Introduction
Effects of oestrogens on egg transport in various species have been the subject of numerous investigations from the classic studies of Burdick & Pincus (1935) to the definitive experiments of Humphrey (1968) . The action of progesterone, however, has received much less attention and most of the available data is from work in rabbits. This work, reviewed by Chang (1976) , indicates that progestagens given after ovulation do not produce marked or consistent changes in the rate of egg transport but when given before ovulation cause acceleration and premature entry of embryos into the uterus. Preovulatory progesterone might be active by virtue of its metabolic conversion to oestrogen, but Kendle & Telford (1970) showed similar acceleration following administration of megestrol acetate, a progestagen which does not have oestrogenic activity and is not easily aromatized metabolically (David, Edwards, Fellows & Plummer, 1963) . Accele¬ ration of egg transport was also observed in these experiments when administration of megestrol acetate was continued up to the day of autopsy (Day 1, 2 or 3 of pregnancy), indicating that the effect was due to progestagen administration and not to progestagen withdrawal. Similar effects of preovulatory progestagen administration have not to date been reported in the mouse.
In the rat post-ovulatory ovariectomy does not modify the rate of egg transport (Alden, 1942) , suggesting that the process was not controlled by post-ovulatory secretion of ovarian hormones in this species. Similar experiments have not, however, been reported in the mouse.
The control of oviduct function may be explained by the hypothesis that the sequence of muscular activities which result in the normal process of egg transport is initiated by the preovulatory secretion of progesterone and is subsequently independent of further hormone secretion. Administration of progesterone at a time earlier than the preovulatory peak would therefore cause premature activation of oviduct function and accelerated embryo transport. The present work was undertaken to see whether this hypothesis could be evaluated by using antiprogestational steroids in the mouse. Since no entirely specific agents of this type are available two steroids with different mechanisms of antiprogestational activity and different spectra of other biological activities were used. RMI 12,936 (17ß-hydroxy-7a methyl androst-5-en-3-one) is an antiprogestational steroid with weak oestrogenic, antioestrogenic and androgenic activities; it inhibits progesterone secretion and may be metabolized to a further compound which antagonizes the effects of progesterone (Kendle, 1975 (Kendle, , 1976 (Kendle, , 1978 Grunwell, Benson, Johnston & Petrow, 1976; Geddes, Kendle, Shanks & Steven, 1979) . R2323 (13-ethyl-17-hydroxy-18,19-dinor-17a-pregna-4,9,ll-trien-20-yn-3-one) has weak oestrogenic, weak andro¬ genic and antioestrogenic activities and is a competitive antagonist of progesterone (Sakiz & Azadian-Boulanger, 1971; Sakiz, Azadian-Boulanger & Raynaud, 1974; Raynaud et al, 1975 ).
Materials and Methods
Albino mice of the RGIT/SLAC strain were housed as described previously (Lee & Kendle, 1979 (Welch, 1947 The mean numbers of embryos recovered were within the range 9-5 ± 3-7 to 14-1 + 1-0 with no significant differences between groups (multiple range / test). (Kendle, 1978) 
